2021 was issued by the Judicial Magistrate, Tiruchengode to MedPlus Pharmacy, to appear before the Judicial
Magistrate on March 5, 2021. The matter is currently pending.

14. Pursuant to a complaint filed by the Drugs Inspector, a summon was issued to Optival, the director, project manager
and supervisor of Optival by the 1Vth Metropolitan Magistrate, Saidapet, Chennai, on September 15, 2021, to answer
a charge punishable under Section 18 (c) and 27 (d) of the Drugs and Cosmetics Act, read with Rule 65 (2) and 65
(3)(1) of the Drugs and Cosmetics Rules. The matter is currently pending.

MHSPPL

For details in relation to CC No. 279/2020, see “Litigation against our Subsidiaries — Actions Taken by Regulatory and
Statutory Authorities — point 13” on page 308.

Litigation by our Subsidiaries

Material Civil Litigation

Except as mentioned below, as of the date of this Prospectus, there are no pending material civil litigation by our Subsidiaries.
Optival had lent a sum of 226 million against collateral of immovable property to Rama Mohan Reddy (“Rama Mohan”), which
Rama Mohan failed to repay. Optival invoked the arbitration clause under the loan agreement between Optival and Rama
Mohan, for recovery of 239.53 million inclusive of interest. The arbitration award by a sole arbitrator was passed in favour of
Rama Mohan. Optival filed an appeal against the award before the City Civil Court, Hyderabad bearing O.P.No.2233/2018.
The matter is currently pending.

Criminal Litigation

Nil

Litigation involving our Promoters

Actions Taken by Regulatory and Statutory Authorities against our Promoter, Gangadi Madhukar Reddy

For details in relation to CC No. 2410/2014, CC No. 178/2016 and CC No. 279/2020 see ~ “Litigation against our Subsidiaries
~ Actions Taken by Regulatory and Statutory Authorities — point 3, 5 and 13” on pages 306, 306 and 308.

Litigation involving our Directors
Actions Taken by Regulatory and Statutory Authorities against our Director, Gangadi Madhukar Reddy

For details in relation to CC No. 2410/2014, CC No. 178/2016 and CC No. 279/2020, see — “Litigation against our Subsidiaries
~ Actions Taken by Regulatory and Statutory Authorities — point 3, 5 and 13” on page 306, 306 and 308.

Litigation involving our Group Company
As of the date of this Prospectus, there are no pending litigation involving our Group Entities that are material to the Company.
Tax Proceedings

Except as disclosed below, there are no claims related to direct and indirect taxes involving our Company, Subsidiaries,
Directors and Promoters.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nature of case Number of cases ‘Amount involved (in & million)
Proceedings involving the Company

Direct Tax Nil Nil
Indirect Tax Nil Nil
Proceedings involving the Subsidiaries

Direct Tax 6 304.61
Indirect Tax Z 9.72
Proceedings involving the Director

Direct Tax Nil Nil
Indirect Tax Nil Nil
Proceedings involving the Promoters

Direct Tax Nil Nil
Indirect Tax Nil Nil

 

 

 

 

Material tax proceedings involving our Subsidiaries
Optival

309
